ALLIQUA BIOMEDICAL INC - COM NEW (ALQA)

CUSIP: 019621200

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM NEW
Total 13F shares
4,596,438
Share change
+224,355
Total reported value
$23,901,000
Price per share
$5.20
Number of holders
24
Value change
+$1,162,412
Number of buys
15
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 019621200?
CUSIP 019621200 identifies ALQA - ALLIQUA BIOMEDICAL INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) as of Q1 2015

As of 31 Mar 2015, ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,596,438 shares. The largest 10 holders included J. Goldman & Co LP, PERCEPTIVE ADVISORS LLC, SUFFOLK CAPITAL MANAGEMENT LLC, THOMSON HORSTMANN & BRYANT INC, SENZAR ASSET MANAGEMENT, LLC, PURA VIDA INVESTMENTS, LLC, Broadfin Capital, LLC, VANGUARD GROUP INC, Healthcare Value Capital, LLC, and Leonard Capital Management INC. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.